Trials / Completed
CompletedNCT03653260
A Study to Evaluate the Efficacy and Safety of Zingo in Chinese Children
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety in Chinese Children
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 288 (actual)
- Sponsor
- Lee's Pharmaceutical Limited · Industry
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the efficacy and safety of Zingo in treating pain associated with venipunture and peripheral venous cannulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine (Zingo) | 0.5 mg lidocaine, 20 bar pressure |
| DRUG | Placebo | Placebo injector, 20 Bar pressure, empty injector |
Timeline
- Start date
- 2018-08-15
- Primary completion
- 2019-02-28
- Completion
- 2019-05-21
- First posted
- 2018-08-31
- Last updated
- 2019-09-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03653260. Inclusion in this directory is not an endorsement.